Patent Assignment
Reel/Frame 058274/0125
Assignment of Assignor's Interest
Recorded: 2021-12-02
Pages: 3
Assignor
ORLANDO CANCER CENTER, INC.
Executed: 2011-05-19
Assignee
BIOCURITY, INC.
4074 TENITA DRIVE, WINTER PARK, FLORIDA, 32792
Covered Property
(1)
Cerium Oxide Nanoparticle Formulation for Use in Skin Radioprotection and Associated Methods
Patent:
11,116,792 →
Application:
14/860,044 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 2, 2021
From: BAKER, CHERYL H.
To: BIOCURITY, INC.
Reel/Frame 058273/0983 →
Assignment of Assignor's Interest
Dec 2, 2021
From: JENKINS, D. WAYNE
To: ORLANDO CANCER CENTER, INC.
Reel/Frame 058274/0049 →
Assignment of Assignor's Interest
Dec 2, 2021
From: SEAL, SUDIPTA
To: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 058274/0166 →
License
Dec 3, 2021
From: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
To: BIOCURITY, INC.
Reel/Frame 058300/0571 →
Change of Name
Dec 20, 2021
From: BIOCURITY, INC.
To: BIOCURITY PHARMACEUTICALS INC.
Reel/Frame 058549/0917 →
Change of Name
Feb 2, 2022
From: BIOCURITY HOLDINGS, INC.
To: BIOCURITY PHARMACEUTICALS INC.
Reel/Frame 058946/0488 →